Browse All

Current Filters

CLEAR FILTER x

TITLE

Ocrelizumab for Pediatric Relapsing Multiple Sclerosis

Author:AlMojel, Malak   Ahmed, Samar   Al-Hashel, Jasem   Alroughani, Raed   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.003  

Author Institution:Amiri Hospital, Kuwait , Kuwait City , Kuwait  Ibn Sina Hospital, Kuwait, Kuwait City, Kuwait  Ibn Sina Hospital, Kuwait City , Kuwait  Amiri Hospital , Kuwait, Kuwait  

Novel Observations in the Management of Relapsing Non-syndromic Pediatric Tumefactive Demyelinating Lesions

Author:Todd, Hannah   Yarimi, Jonathan   Fisher, Kristen   Lotze, Timothy   Shukla, Nikita   Sandweiss, Alexander   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.011  

Author Institution:Baylor College of Medicine, Houston, TX  Baylor College of Medicine , Houston, TX  

Sublinical Atherosclerosis in Patients with Relapsing-remitting Multiple Sclerosis: A 5-year Cohort Study

Author:Omerzu, Tomaz   Karakatic, Sanja   Hojs Fabjan, Tanja   Hojs, Radovan   Gorenjak, Mario   Potocnik, Uros   Magdic, Jozef   

Session Name:P5: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 1  

Topic:Multiple Sclerosis  

Program Number:P5.014  

Author Institution:University Medical Centre Maribor, Maribor, Slovenia  Faculty of Medicine University of Maribor, Maribor, Slovenia  

Retinal Layer Thinning for Monitoring Disease-modifying Treatment in Relapsing Multiple Sclerosis—Evidence for Applying a Rebaselining Concept

Author:Bsteh, Gabriel   Hegen, Harald   Krajnc, Nik   Altmann, Patrick   Auer, Michael   Berek, Klaus   Kornek, Barbara   Leutmezer, Fritz   Macher, Stefan   Monschein, Tobias   Ponleitner, Markus   Rommer, Paulus   Schmied, Christiane   Zebenholzer, Karin   Zulehner, Gudrun   Zrzavy, Tobias   Deisenhammer, Florian   Di Pauli, Franziska   Pemp, Berthold   Berger, Thomas   

Session Name:P6: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 2  

Topic:Multiple Sclerosis  

Program Number:P6.005  

Author Institution:Medical University Vienna, Department of Neurology, Vienna, Austria  Medical University of Innsbruck, Innsbruck, Austria  Medical University of Vienna, Vienna, Austria  Medical University of Vienna, Wien, Austria  

Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod

Author:Kappos, Ludwig   Arnold, Douglas   Pachai, Chahin   Eddy, Nathanial   Osik, Jason   Cheng, Chun-Yen   Harris, Sarah   Deboer, Erik   Freeman, Leorah   Granziera, Cristina   Filippi, Massimo   

Session Name:P6: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 2  

Topic:Multiple Sclerosis  

Program Number:P6.006  

Author Institution:Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montreal, QC, Canada  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Dell Medical School, The University of Texas at Austin, Austin, Texas, Austin, TX  Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland  Department of Neurology, University Hospital Basel, Switzerland  Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy, Milan, Italy